HemaSphere (Jun 2022)
PB2048: EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: A RETROSPECTIVE MULTICENTER STUDY
- C. Chen,
- S. Ma,
- F. Yan,
- H. Zhao,
- X. Chu,
- H. Zhang,
- X. Deng,
- Z. Liu,
- D. Li,
- T. xiao,
- C. Yuan,
- Z. Wang,
- G. Liu,
- M. Hou,
- Y. Yu
Affiliations
- C. Chen
- 1 Qilu Hospital of Shandong University, Jinan
- S. Ma
- 1 Qilu Hospital of Shandong University, Jinan
- F. Yan
- 1 Qilu Hospital of Shandong University, Jinan
- H. Zhao
- 2 Affiliated Hospital of Qingdao University, Qingdao
- X. Chu
- 3 The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai
- H. Zhang
- 4 Linyi People’s Hospital, Linyi
- X. Deng
- 5 Weihai Municipal Hospital, Weihai
- Z. Liu
- 6 Shandong Provincial Hospital of Traditional Chinese Medicine
- D. Li
- 7 Central Hospital Affiliated to Shandong First Medical University, Jinan
- T. xiao
- 8 Liaocheng People’s Hospital, Liaocheng
- C. Yuan
- 9 Qilu Hospital of Shandong University Dezhou Hospital, Dezhou
- Z. Wang
- 10 Zibo Central Hospital, Zibo
- G. Liu
- 11 Shengli qilfield Central Hospital, Dongying, China
- M. Hou
- 1 Qilu Hospital of Shandong University, Jinan
- Y. Yu
- 1 Qilu Hospital of Shandong University, Jinan
- DOI
- https://doi.org/10.1097/01.HS9.0000851024.61601.a6
- Journal volume & issue
-
Vol. 6
pp. 1919 – 1920
Abstract
No abstracts available.